Genetics

This article explores recent research revealing that while familial aggregation of multiple sclerosis reflects a higher burden of genetic and environmentally mediated risk factors—particularly involving HLA variants, vitamin D pathways, and metabolic predispositions—it does not influence the early clinical course of the disease. Drawing on a large prospective cohort of clinically isolated syndrome patients, the study highlights a critical dissociation between mechanisms governing disease susceptibility and those driving progression, offering new insights into MS pathophysiology and implications for risk prediction and therapeutic strategies.